chloroquine has been researched along with ro13-9904 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altinay, G; Ermantaş, N; Okten, O; Oktun, MT; Soy, M; Tunçbilek, N; Turgut, B | 1 |
Chitnis, DS; Khan, YZ; Rao, G | 1 |
Fenollar, F; Feurle, GE; Moos, V; Raoult, D; Schneider, T | 1 |
3 other study(ies) available for chloroquine and ro13-9904
Article | Year |
---|---|
Nocardiosis in a patient with primary anti-phospholipid syndrome.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Antirheumatic Agents; Ceftriaxone; Chloroquine; Female; Humans; Immunocompromised Host; Methylprednisolone; Nocardia Infections; Thrombocytopenia; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Chikungunya infection in neonates.
Topics: Alphavirus Infections; Anti-Bacterial Agents; Ceftriaxone; Chikungunya virus; Chloroquine; Humans; Infant, Newborn; Male; Risk Factors | 2008 |
The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazole.
Topics: Anti-Bacterial Agents; Ceftriaxone; Central Nervous System Diseases; Chloroquine; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Male; Meropenem; Microbial Sensitivity Tests; Minocycline; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Whipple Disease | 2012 |